Evidence map›Paper›PMID 36404625›Full record

ArticleCancer medicine2023

Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer.

Alice Guan, Janet K Shim, Laura Allen, Mei-Chin Kuo, Kathie Lau, Zinnia Loya, James D Brooks, Peter R Carroll, Iona Cheng, Benjamin I Chung and 11 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. A Scoping Review of Stigma Related to Prostate Cancer in Black Men.Journal of racial and ethnic health disparities · 2025
    Article
  5. Review
  6. Article
  7. Comparative analysis of treatment decision-making in patients with localized prostate and cervical cancer: what influences receiving surgery or radiotherapy?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Alice GuanDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.ORCID 0000-0002-9075-4230
Janet K ShimDepartment of Social & Behavioral Sciences, University of California, San Francisco, California, USA.
Laura AllenDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Mei-Chin KuoDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Kathie LauDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Zinnia LoyaDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
James D BrooksDepartment of Urology, Stanford University, Stanford, California, USA.
Peter R CarrollDepartment of Urology, University of California, San Francisco, California, USA.
Iona ChengDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Benjamin I ChungDepartment of Urology, Stanford University, Stanford, California, USA.
Mindy C DeRouenDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.ORCID 0000-0002-7198-7629
Dominic L FroschCenter for Health Systems Research, Sutter Health/Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA.
Todd GoldenDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
John T LeppertDepartment of Urology, Stanford University, Stanford, California, USA.ORCID 0000-0001-9980-3863
Daphne Y LichtensztajnDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.ORCID 0000-0003-2906-3868
Qian LuDepartment of Health Disparities Research, University of Texas MD-Anderson Cancer Center, Houston, Texas, USA.
Debora L OhDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.ORCID 0000-0001-8229-5372
Weiva SiehDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Michelle WadhwaDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Scarlett L GomezDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.ORCID 0000-0002-5143-4867
Salma Shariff-MarcoDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.ORCID 0000-0002-2541-3333
University of California, San Francisco · USStanford University · USIcahn School of Medicine at Mount Sinai · USSutter Health · USThe University of Texas MD Anderson Cancer Center · US

Funding

Active surveillance and patient reported outcomes in a diverse population of prostate cancer patientsR01CA211141 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOMEZ, SCARLETT L · 2017 to 2022
$3.1M
A lifecourse approach to evaluating the effect of structural stigma on cancer risk factors among sexual minoritiesF31CA257351 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUAN, ALICE · 2021 to 2023
$114k
NCI NIH HHS F31 CA257351NCI NIH HHS R01 CA211141
6 · The paper itself

Abstract

backgroundFactors that influence prostate cancer treatment decisions are complex, multifaceted, and personal, and may vary by race/ethnicity. Although research has been published to quantify factors involved in decision-making, these studies have been limited to primarily white, and to a lesser extent, Black patients, and quantitative studies are limited for discerning the cultural and contextual processes that shape decision-making.

methodsWe conducted 43 semi-structured interviews with a racially and ethnically diverse sample of patients diagnosed with low- and very-low risk prostate cancer who had undergone treatment for their prostate cancer. Interviews were transcribed, independently coded, and analyzed to identify themes salient for decision-making, with attention to sociocultural differences.

resultsWe found racial and ethnic differences in three areas. First, we found differences in how socialized masculinity influenced patient's feelings about different treatment options. Second, we found that for some men, religion and spirituality alleviated anxiety associated with the active surveillance protocol. Finally, for racially and ethnically minoritized patients, we found descriptions of how historic and social experiences within the healthcare system influenced decision-making.

conclusionsOur study adds to the current literature by expounding on racial and ethnic differences in the multidimensional, nuanced factors related to decision-making. Our findings suggest that factors associated with prostate cancer decision-making can manifest differently across racial and ethnic groups, and provide some guidance for future research.

Indexed as

EthnicityProstatic NeoplasmsTerminal CareDecision MakingHumansMaleQualitative Researchprostate cancerpsychosocial studiesquality of lifetranslational research

Identifiers

PMID36404625
PMCPMC10028041
OpenAlexW4309517538

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read43
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.